Hematology TimesFDA approves ofatumumab in combination for CLLApril 18, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Oncology PracticeNovel epigenetic treatment showed activity in hematologic cancersApril 17, 2014Leukemia, Myelodysplasia, Transplantation
Hematology TimesProtective cells are impaired in aggressive CLLApril 17, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology TimesPatient perception of control affects satisfactionApril 16, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Hematology TimesGroup describes mechanism of resistance in CLLApril 16, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology TimesDual kinase inhibitor targets heterogeneity in AMLApril 15, 2014Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesASCO releases guidelines for managing cancer survivorsApril 15, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated Issues
Oncology PracticeNew indices risk-stratify adults with cytogenetically normal acute myeloid leukemiaApril 14, 2014Leukemia, Myelodysplasia, Transplantation
Oncology PracticeMinimal residual disease associated with overall survival in leukemiaApril 14, 2014Leukemia, Myelodysplasia, Transplantation
Hematology TimesPredicting risk of death in childhood cancer survivorsApril 13, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsRelated Issues
Hematology TimesMolecule can increase Hb in anemic cancer patientsApril 12, 2014AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Oncology Practice‘Extremely exciting’ results from phase I trial of novel cancer metabolism agent April 11, 2014Leukemia, Myelodysplasia, Transplantation
Hematology TimesHow NK cells kill abnormal blood cellsApril 10, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Hematology TimesCompound is potent FLT3 inhibitor, team saysApril 10, 2014Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesEnrollment stalled for CAR T-cell studyApril 8, 2014Leukemia, Myelodysplasia, TransplantationPharmacyALL
